Narrow search
Showing 1 - 10 of 40,222
Cover Image
Regulation and welfare : evidence from Paragraph IV generic entry in the pharmaceutical industry
Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - 2011
Persistent link: https://www.econbiz.de/10009234148
Cover Image
Pay-for-delay patent settlement, generic entry and welfare
Ding, Yucheng; Zhao, Xin - In: International journal of industrial organization 67 (2019), pp. 1-18
Persistent link: https://www.econbiz.de/10012321579
Cover Image
Newton's first law as applied to pharmacies : why entry order matters for generics
Shajarizadeh, Ali; Grootendorst, Paul V.; Hollis, Aidan - In: International journal of the economics of business 22 (2015) 2, pp. 201-217
Persistent link: https://www.econbiz.de/10011405941
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Generic competition and price regulation in pharmaceuticals : evidence from the European Union
Tuncay, Berna - In: Dynamic optics in economics : quantitative, …, (pp. 221-240). 2020
Persistent link: https://www.econbiz.de/10013040759
Cover Image
Optimal patent policy for pharmaceutical industry
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020
Persistent link: https://www.econbiz.de/10012439514
Cover Image
Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market
Bokhari, Farasat A. S.; Yan, Weijie - 2020
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
Cover Image
Drug detailing and doctors' prescription decisions : the role of information content in the caf of competitive entry
Kappe, Eelco; Stremersch, Stefan - In: Marketing science : the marketing journal of the … 35 (2016) 6, pp. 915-933
Persistent link: https://www.econbiz.de/10011617439
Cover Image
Pseudo-generic products and barriers to entry in pharmaceutical markets : reply
Kong, Ying; Seldon, James R. - In: Review of industrial organization : RIO 28 (2006) 2, pp. 189-193
Persistent link: https://www.econbiz.de/10003304144
Cover Image
Entry and competition in the pharmaceutical market following patent expiry : evidence from macro and micro data
Appelt, Silvia - 2011
Persistent link: https://www.econbiz.de/10009243199